UNITED ~~STATES~~STATESSECURITIES AND EXCHANGE COMMISSIONWashington, D.C. 20549

~~SECURITIES~~Form ~~AND EXCHANGE COMMISSION~~6-K

~~Washington,~~REPORT ~~D.C.~~OF ~~20549~~FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934

~~FORM~~For ~~6-K~~the month of March 2026

REPORT OF FOREIGN PRIVATE ISSUER

PURSUANT TO RULE 13a-16 OR 15d-16

UNDER THE SECURITIES EXCHANGE ACT OF 1934

For the Month of March 2026

Commission File Number: 001-40488

~~MOLECULAR~~Molecular ~~PARTNERS~~Partners AG(Translation of registrant's name into English)

~~(Exact~~Wagistrasse ~~name~~148952 Zurich-SchlierenSwitzerland(Address of ~~registrant~~principal asexecutive ~~specified in its charter~~office)

~~Wagistrasse~~Indicate 14by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.Form 20-F [ X ] Form 40-F [ ]

~~8952~~On ~~Zürich-Schlieren~~March 12, 2026, the Registrant issued a press release, a copy of which is attached hereto as Exhibit 99.1 and is incorporated herein by reference. (c) Exhibit 99.1. Press release dated March 12, 2026

Switzerland

Telephone: +41 447557700

(Address of registrant’s principal executive offices)

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F:

☒ Form 20-F ☐ Form 40-F

EXPLANATORY NOTE

On March 12, 2026, Molecular Partners AG published its Annual Report 2025, a copy of which is attached hereto as Exhibit 99.1, and is incorporated by reference herein.

Exhibit 99.1 Annual Report 2025

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

MOLECULAR PARTNERS AG

		Molecular Partners AG
		(Registrant)


Date: March 12, 2026		/s/ PATRICK AMSTUTZ
		Patrick Amstutz
		Chief Executive Officer

(Registrant)

Date: March 12, 2026 /s/ PATRICK AMSTUTZ

Name: Patrick Amstutz

Title: Chief Executive Officer

Filing Compare · MOLECULAR PARTNERS AG